John E. Mullinax
Impact in
- Oncology top 2%
- CAR-T cell therapy research
- COVID-19 and healthcare impacts
- Cancer Immunotherapy and Biomarkers
- Pancreatic and Hepatic Oncology Research
- Cancer Cells and Metastasis
-
- Sarcoma Diagnosis and Treatment
- Gastric Cancer Management and Outcomes
Papers in
- Oncology 33
- CAR-T cell therapy research 8
- Cancer Immunotherapy and Biomarkers 7
- Pancreatic and Hepatic Oncology Research 6
- Cancer Cells and Metastasis 5
- COVID-19 and healthcare impacts 5
- Cutaneous Melanoma Detection and Management 2
-
- Sarcoma Diagnosis and Treatment 21
- Co-authors
- Itzhak Avital (9 shared papers)Ricardo González (14 shared papers)Alexander Stojadinovic (7 shared papers)Russell Charles Langan (6 shared papers)Jonathan S. Zager (12 shared papers)Udo Rudloff (9 shared papers)Jonathan Matthew Hernandez (8 shared papers)Sharona B Ross (5 shared papers)
- Journals
- Annals of Surgical Oncology (10 papers)Journal for ImmunoTherapy of Cancer (7 papers)British journal of surgery (5 papers)Journal of Cancer (5 papers)Cancer Control (4 papers)
- Partner nations
- United StatesFranceUnited Kingdom
In The Last Decade
John E. Mullinax
82 papers receiving 2.6k citations
John E. Mullinax's Hit Papers
Peers
Comparison fields: 5 of 66
- Oncology 1.1k
- Pulmonary and Respiratory Medicine 481
- Hepatology 74
- Surgery 231
- Immunology 77
Countries citing papers authored by John E. Mullinax
This map shows the geographic impact of John E. Mullinax's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by John E. Mullinax with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites John E. Mullinax more than expected).
Fields of papers citing papers by John E. Mullinax
This network shows the impact of papers produced by John E. Mullinax. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by John E. Mullinax. The network helps show where John E. Mullinax may publish in the future.
Co-authors
The 25 scholars most cited alongside John E. Mullinax, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 87 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Tumor-infiltrating lymphocyte treatment for anti-PD-1-resistant metastatic lung cancer: a phase 1 trial Hit paper breakdown → | 2021 | 343 |
| 2 | 2021 | 223 | |
| 3 | 2014 | 185 | |
| 4 | 2021 | 181 | |
| 5 | 2020 | 170 | |
| 6 | 2020 | 98 | |
| 7 | 2013 | 96 | |
| 8 | 2009 | 95 | |
| 9 | 2018 | 86 | |
| 10 | 2013 | 67 | |
| 11 | 2020 | 67 | |
| 12 | 2011 | 66 | |
| 13 | 2020 | 56 | |
| 14 | 2012 | 54 | |
| 15 | 2012 | 50 | |
| 16 | 2022 | 44 | |
| 17 | 2018 | 39 | |
| 18 | 2021 | 39 | |
| 19 | 2021 | 37 | |
| 20 | 2022 | 34 |
About John E. Mullinax
John E. Mullinax is a scholar working on Oncology, Pulmonary and Respiratory Medicine, Hepatology, Rheumatology and Neurology, having authored 87 papers that have together received 2.7k indexed citations. Recurring topics across this work include Sarcoma Diagnosis and Treatment (21 papers), CAR-T cell therapy research (8 papers), Cancer Immunotherapy and Biomarkers (7 papers), Pancreatic and Hepatic Oncology Research (6 papers), Cancer Cells and Metastasis (5 papers), COVID-19 and healthcare impacts (5 papers), Cutaneous Melanoma Detection and Management (2 papers) and Neurofibromatosis and Schwannoma Cases (2 papers). The work is most often cited by research in Oncology (1.1k citations), Pulmonary and Respiratory Medicine (481 citations), Hepatology (74 citations), Surgery (231 citations) and Immunology (77 citations). John E. Mullinax has collaborated with scholars based in United States, France and United Kingdom. Frequent co-authors include Itzhak Avital, Ricardo González, Alexander Stojadinovic, Russell Charles Langan, Jonathan S. Zager, Udo Rudloff, Jonathan Matthew Hernandez, Sharona B Ross, Gordon W. Wiegand and Desireé Villadolid. Their work appears in journals such as Annals of Surgical Oncology, Journal for ImmunoTherapy of Cancer, British journal of surgery, Journal of Cancer and Cancer Control.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.